Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FKRLU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,554
Award facts
- Contract value 100% obligated
- $5,554.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On July 21, 2025, the Defense Logistics Agency awarded a delivery order valued at $5,554.48 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, with an ultimate completion date of August 11, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for diverse medical products ranging from prescription medications to biologics and specialty pharmaceuticals. The company's core business involves distributing branded and generic drugs, over-the-counter medications, and medical consumables directly to military and federal healthcare facilities. This specific delivery order for Nexplanon implants—a contraceptive device—represents a routine procurement within the company's established portfolio of pharmaceutical distribution services to support DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FKRLU?
SPE2DB25FKRLU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FKRLU worth?
The government has obligated $5,554 on SPE2DB25FKRLU.
Is contract SPE2DB25FKRLU an order under another contract?
Yes. SPE2DB25FKRLU is a delivery order under SPE2DB24D9314, an indefinite delivery contract.
Was contract SPE2DB25FKRLU competed?
The extent of competition for SPE2DB25FKRLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award